Search research articles
Contact Us
Filters
Showing results (101-110 of 184) with videos related to
Page
of 19
Sort By:
The Journal of Clinical Investigation
|
June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation
Jaimy Joy, Ana Gervassi, Lennie Chen, et al.
Annals of Neurology
|
December 11, 2008
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy
Ronald J Ellis, Jennifer Marquie-Beck, Patrick Delaney, et al.
Neurology
|
December 16, 2014
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people
David B Clifford, Florin Vaida, Yu-Ting Kao, et al.
The Journal of Antimicrobial Chemotherapy
|
January 22, 2013
Etravirine in CSF is highly protein bound
Anh Nguyen, Steven Rossi, David Croteau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection
Linda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
Plos Pathogens
|
April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
Plos One
|
May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection
Eric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
The Journal of Infectious Diseases
|
August 23, 2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
Margaret A Fischl, Heather J Ribaudo, Ann C Collier, et al.
Journal of Virology
|
July 31, 2015
Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection
Justine E Sunshine, Brendan B Larsen, Brandon Maust, et al.
The Journal of Antimicrobial Chemotherapy
|
November 25, 2010
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
Brookie M Best, Peter P Koopmans, Scott L Letendre, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 184) with videos related to
Sort By:
Page
of 19
The Journal of Clinical Investigation
|
June 4, 2024
Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation
Jaimy Joy, Ana Gervassi, Lennie Chen, et al.
Annals of Neurology
|
December 11, 2008
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy
Ronald J Ellis, Jennifer Marquie-Beck, Patrick Delaney, et al.
Neurology
|
December 16, 2014
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people
David B Clifford, Florin Vaida, Yu-Ting Kao, et al.
The Journal of Antimicrobial Chemotherapy
|
January 22, 2013
Etravirine in CSF is highly protein bound
Anh Nguyen, Steven Rossi, David Croteau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 6, 2009
Tolerability and efficacy of PI versus NNRTI-based regimens in subjects receiving HAART during acute or early HIV infection
Linda G Apuzzo, Florin Vaida, Joel E Gallant, et al.
Plos Pathogens
|
April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
Plos One
|
May 19, 2010
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection
Eric S Rosenberg, Barney S Graham, Ellen S Chan, et al.
The Journal of Infectious Diseases
|
August 23, 2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
Margaret A Fischl, Heather J Ribaudo, Ann C Collier, et al.
Journal of Virology
|
July 31, 2015
Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection
Justine E Sunshine, Brendan B Larsen, Brandon Maust, et al.
The Journal of Antimicrobial Chemotherapy
|
November 25, 2010
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
Brookie M Best, Peter P Koopmans, Scott L Letendre, et al.
Page
of 19